Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Respiratory syncytial virus is the second most common cause of infant mortality and a major cause of morbidity and mortality in older adults (aged >60 years).
9th Congress of the European Academy of Paediatric Societies
October 7-11 2022, Barcelona and online
|
ESWI Airborne: Meet the Members
Flu shots for children? Why this should be more on the radar
ESWI Board Member Terho Heikkinen, Professor in paediatrics at the University of Turku in Finland talks about paediatric infectious diseases. Learn about why the flu shot is to be recommended in children.
RSV Disease in a COVID-19 era
Fourth webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Peter ...
Childhood Influenza Vaccination and treatment in a COVID-19 era
Second webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and George...
Vaccination in a COVID-19 era
First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ...
Video
Partner Organisations
|
7th Influenza Conference 2020
Should we introduce national live vaccination programmes for children?
ESPID/ESWI joint symposium supported by AZ
